BAY CITY CAPITAL LLC 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jun 12, 2018
Insider Transaction Report
Form 4
BAY CITY CAPITAL LLC
Director10% Owner
Transactions
- Sale
Common Stock
2018-06-11$287.46/sh−274,092$78,790,486→ 5,264,382 total(indirect: See Footnotes) - Sale
Common Stock
2018-06-11$287.46/sh−5,908$1,698,314→ 113,472 total(indirect: See Footnotes)
Footnotes (3)
- [F1]Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.
- [F2]The securities are held by Fund IV.
- [F3]The securities are held by Co-Investment IV.